Cortizone-10
Allegations: Falsely marketing products with 1% hydrocortisone as “maximum strength”
Unisom SleepGels, PM Pain, and SleepMinis
Case Name (Date)
Amaral et al. v. Chattem Inc. d/b/a Opella North America and Sanofi-Aventis U.S. LLC
26-cv-5474, N.D. Cal.
(June 2026)
Product/Service
Unisom SleepGels, PM Pain, SleepMinis
Allegations
Falsely marketing products as “non-habit forming” when their active ingredient (diphenhydramine HCI) can lead to dependence and abuse
Status
Pending
Class-Action Tracker
Cortizone-10 Products
Allegations: Misleadingly marketing products as “Maximum Strength”
ACT Dry Mouth Lozenges
Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin
Unisom Simple Slumbers
Allegations: False natural claims
Dulcolax
Allegations: False natural claims
ACT Total Care Anticavity Fluoride Mouthwash
ACT Restoring Mouthwash
ACT® Restoring™ Anticavity Fluoride Mouthwash
The Latest
2022 Reasonable Consumer Quiz
See how you stack up.
Aspercreme
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
ACT Dry Mouth Mouthwash, Lozenges
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Nasacort
Makers of nasal allergy spray told to cease consumer preference claims.